While a general solution for rod regulation remains elusive, the general lack of effective therapies for Alzheimer’s disease and its increasing incidence makes all potential therapeutic targets, including cofilin-actin rods, deserving of further investigation. Here, CFL1 is linked to Alzheimer disease.